Pfizer-BioNTech’s covid-flu jab disappoints in trial

  Germany’s BioNTech and US pharma giant Pfizer said Friday they had suffered a setback in a late-stage trial of their combined mRNA vaccine against Covid-19 and influenza. READ ALSO:Pfizer lifts 2024 outlook, citing progress in non-Covid business In